Optimized retroviral transduction protocol for human progenitor cells utilizing fibronectin fragments

Cytotherapy

Volumn 2, Issue 6, 2000, Pages 429-438

  Trarbach, T ^a   Greifenberg, S ^a   Bardenheuer, W ^a   Elmaagacli, A ^b   Hirche, H ^b   Flasshove, M ^a   Seeber, S ^a   Moritz, T ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

Author keywords

Cytokines; Fibronectin; Hematopoietic cells; Retroviral gene transfer

Indexed keywords

CD34 ANTIGEN; CH 296; CYTOKINE; ERYTHROPOIETIN; FIBRONECTIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; HEPARIN; PEPTIDE FRAGMENT; UNCLASSIFIED DRUG; VIRUS VECTOR; HEMOPOIETIC GROWTH FACTOR;

ARTICLE; CELL STIMULATION; CLONOGENIC ASSAY; CONTROLLED STUDY; GENE EXPRESSION; GENE TRANSFER; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MONONUCLEAR CELL; NONHUMAN; PROTEIN LOCALIZATION; RETROVIRUS; STEM CELL; TECHNIQUE; CELL ADHESION; CELL CULTURE; CELL DIVISION; CELL LINE; CYTOLOGY; DRUG EFFECT; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; METABOLISM; METHODOLOGY; STEM CELL TRANSPLANTATION; TIME;

ANTIGENS, CD34; CELL ADHESION; CELL CULTURE; CELL DIVISION; CELL LINE; FIBRONECTINS; GENETIC VECTORS; HEMATOPOIETIC CELL GROWTH FACTORS; HEPARIN; HUMAN; PEPTIDE FRAGMENTS; RETROVIRIDAE; STEM CELL TRANSPLANTATION; STEM CELLS; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; TRANSDUCTION, GENETIC;

EID: 0034478163     PISSN: 14653249     EISSN: None     Source Type: Journal    
DOI: 10.1080/146532400539378     Document Type: Article

References (37)

1. Human gene therapy comes of age
2. Human gene therapy
3. The basic science of gene therapy
4. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia
5. Increasing DNA repair methyltransferase levels via bone marrow stem cell transduction rescues mice from the toxic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea, a chemotherapeutic alkylating agent
6. Transfer of drug resistance genes into hematopoietic progenitors to improve chemotherapy tolerance
7. Retrovirus-mediated expression of a DNA repair protein in bone marrow protects hematopoietic cells from nitrosourea-induced toxicity in vitro and in vivo
8. + umbilical cord blood progenitor cells with a mutated dihydrofolate reductase cDNA
9. Transfer of the cytidine deaminase cDNA into hematopoietic cells
10. Lentiviral vectors - The promise of gene therapy within reach?
11. + cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors
12. Preclinical assessment of human hematopoietic progenitor cell transduction in long-term marrow cultures
13. Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: Analysis of gene transduction of long-lived progenitors
14. Improved methods of retroviral vector transduction and production for gene therapy
15. + bone marrow cells
16. The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency retrovirus transduction
17. + bone marrow progenitor cells
18. + peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transfer
19. Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer
20. Human cord blood cells as targets for gene transfer: Potential use in genetic therapies of severe combined immunodeficiency disease
21. Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors
22. Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: Evidence of direct viral binding to chymotryptic carboxy-terminal fragments
23. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells
24. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy
25. Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells
26. Efficient retroviral-mediated gene transfer to human cord blood stem cells with in vivo repopulating potential
27. Optimization of retroviral-mediated gene transfer to human NOD/SCID mouse repopulating cord blood cells through a systematic analysis of protocol variables
28. Construction and use of a safe and efficient amphotropic packaging cell line
29. Support of human hematopoiesis in long-term bone marrow cultures by murine stromal cells selectively expressing the membrane-bound and secreted forms of the human homolog of the steel gene product, stem cell factor
30. + hematopoietic cells
31. Optimizing conditions for gene transfer into human hematopoietic cells
32. + cells in two children
33. + cells transduced over recombinant fibronectin CH-296 fragment
34. Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor
35. The use of granulocyte colony-stimulating factor during retroviral transduction on fibronectin fragment CH-296 enhances gene transfer into hematopoietic repopulating cells in dogs
36. + cells using the recombinant fibronectin fragment CH-296
37. low primitive cells capable of reconstituting long-term cultures in vitro and nonobese diabetic-severe combined immunodeficiency mice in vivo